| Mixtures of multivariate power exponential distributions UJ Dang, RP Browne, PD McNicholas Biometrics 71 (4), 1081-1089, 2015 | 82 | 2015 |
| Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial M Guglieri, PR Clemens, SJ Perlman, EC Smith, I Horrocks, RS Finkel, ... JAMA neurology 79 (10), 1005-1014, 2022 | 69 | 2022 |
| Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study EC Smith, LS Conklin, EP Hoffman, PR Clemens, JK Mah, RS Finkel, ... PLoS medicine 17 (9), e1003222, 2020 | 65 | 2020 |
| Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia BT Mogle, JM Steele, RW Seabury, UJ Dang, WD Kufel International journal of antimicrobial agents 52 (6), 805-810, 2018 | 62 | 2018 |
| Multivariate response and parsimony for Gaussian cluster-weighted models UJ Dang, A Punzo, PD McNicholas, S Ingrassia, RP Browne Journal of Classification 34 (4), 4–34, 2017 | 53 | 2017 |
| Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial JK Mah, PR Clemens, M Guglieri, EC Smith, RS Finkel, M Tulinius, ... JAMA Network Open 5 (1), e2144178-e2144178, 2022 | 49 | 2022 |
| Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne muscular dystrophy Y Hathout, C Liang, M Ogundele, G Xu, SM Tawalbeh, UJ Dang, ... Scientific reports 9 (1), 12167, 2019 | 48 | 2019 |
| Phenethyl Isothiocyanate and Cisplatin Co-Encapsulated in a Liposomal Nanoparticle for Treatment of Non-Small Cell Lung Cancer M Sun, Y Shi, UJ Dang, AJ Di Pasqua Molecules 24 (4), 801, 2019 | 35 | 2019 |
| Serum protein biomarkers for juvenile dermatomyositis: a pilot study SM Tawalbeh, W Marin, GA Morgan, UJ Dang, Y Hathout, LM Pachman BMC Rheumatology 4 (1), 1-15, 2020 | 30 | 2020 |
| Optimization of DOTAP/chol cationic lipid nanoparticles for mRNA, pDNA, and oligonucleotide delivery M Sun, UJ Dang, Y Yuan, AM Psaras, O Osipitan, TA Brooks, F Lu, ... AAPS PharmSciTech 23 (5), 135, 2022 | 28 | 2022 |
| Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys UJ Dang, M Ziemba, PR Clemens, Y Hathout, LS Conklin, ... Human Molecular Genetics 29 (15), 2481-2495, 2020 | 28 | 2020 |
| Families of Parsimonious Finite Mixtures of Regression Models UJ Dang, PD McNicholas Advances in Statistical Models for Data Analysis, 73-84, 2015 | 20 | 2015 |
| Interrogation of dystrophin and dystroglycan complex protein turnover after exon skipping therapy JS Novak, R Spathis, UJ Dang, AA Fiorillo, R Hindupur, CB Tully, ... Journal of Neuromuscular Diseases 8 (s2), S383-S402, 2021 | 19 | 2021 |
| Divergent subgenome evolution after allopolyploidization in African clawed frogs (Xenopus) BLS Furman, UJ Dang, BJ Evans, GB Golding Journal of evolutionary biology 31 (12), 1945-1958, 2018 | 16 | 2018 |
| Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice M Ziemba, M Barkhouse, K Uaesoontrachoon, M Giri, Y Hathout, UJ Dang, ... PLOS ONE 16 (2), e0246507, 2021 | 13 | 2021 |
| Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy M Ogundele, JS Zhang, MV Goswami, ML Barbieri, UJ Dang, JS Novak, ... Life 11 (8), 827, 2021 | 11 | 2021 |
| Model-based clustering and classification using mixtures of multivariate skewed power exponential distributions UJ Dang, MPB Gallaugher, RP Browne, PD McNicholas Journal of Classification, 1-23, 2023 | 10* | 2023 |
| Acute serum protein and cytokine response of single dose of prednisone in adult volunteers R Roy, SJ Soldin, B Stolze, M Barbieri, SM Tawalbeh, N Rouhana, ... Steroids 178, 108953, 2022 | 9 | 2022 |
| Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys S Tawalbeh, A Samsel, H Gordish-Dressman, Y Hathout, UJ Dang Journal of Personalized Medicine 10 (4), 164, 2020 | 8 | 2020 |
| Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial UJ Dang, JM Damsker, M Guglieri, PR Clemens, SJ Perlman, EC Smith, ... Neurology 102 (5), e208112, 2024 | 7 | 2024 |
Eric P HoffmanProfessor, Department of Pharmaceutical Sciences, Binghamton UniversityVerified email at binghamton.edu
